4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-25-112227
Options or other derivatives
- Interim CFO acquired 245,000 shares (grant or award)
- Interim CFO returned 245,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Ellspermann Cory Randall · Interim CFO
Table II: Derivative
10 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-18 | Returned to the company : show line 1 in the form Stock Option (right to buy) | −75,000 | 0 | D |
| 2025-11-18 | Grant or award : show line 2 in the form Stock Option (right to buy) | +75,000 | 75,000 | D |
| 2025-11-18 | Returned to the company : show line 3 in the form Stock Option (right to buy) | −40,000 | 0 | D |
| 2025-11-18 | Grant or award : show line 4 in the form Stock Option (right to buy) | +40,000 | 40,000 | D |
| 2025-11-18 | Returned to the company : show line 5 in the form Stock Option (right to buy) | −30,000 | 0 | D |
| 2025-11-18 | Grant or award : show line 6 in the form Stock Option (right to buy) | +30,000 | 30,000 | D |
| 2025-11-18 | Returned to the company : show line 7 in the form Stock Option (right to buy) | −70,000 | 0 | D |
| 2025-11-18 | Grant or award : show line 8 in the form Stock Option (right to buy) | +70,000 | 70,000 | D |
| 2025-11-18 | Returned to the company : show line 9 in the form Stock Option (right to buy) | −30,000 | 0 | D |
| 2025-11-18 | Grant or award : show line 10 in the form Stock Option (right to buy) | +30,000 | 30,000 | D |
Loading xslF345X05/ownership.xml…